Your browser doesn't support javascript.
loading
The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases.
Shamriz, Oded; Hershko, Alon Y; Talmon, Aviv; Ribak, Yaarit; Elazary, Anat Scheiman; Horev, Liran; NaserEddin, Adeeb; Neuman, Tzahi; Shabat, Sheer; Zlotogorski, Abraham; Tal, Yuval.
Afiliação
  • Shamriz O; Allergy and Clinical Immunology Unit, Department of Medicine, Jerusalem, Israel; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
  • Hershko AY; Allergy and Clinical Immunology Unit, Department of Medicine, Jerusalem, Israel. Electronic address: alonh@hadassah.org.il.
  • Talmon A; Allergy and Clinical Immunology Unit, Department of Medicine, Jerusalem, Israel.
  • Ribak Y; Allergy and Clinical Immunology Unit, Department of Medicine, Jerusalem, Israel.
  • Elazary AS; Rheumatology Unit, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
  • Horev L; Department of Dermatology, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
  • NaserEddin A; Allergy and Clinical Immunology Unit, Department of Medicine, Jerusalem, Israel; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
  • Neuman T; Department of Pathology, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
  • Shabat S; Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
  • Zlotogorski A; Department of Dermatology, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
  • Tal Y; Allergy and Clinical Immunology Unit, Department of Medicine, Jerusalem, Israel.
Allergol Int ; 70(2): 266-268, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33779559
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-5 / Eosinófilos / Subunidade alfa de Receptor de Interleucina-5 / Anticorpos Monoclonais Humanizados / Doenças do Sistema Imunitário Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Allergol Int Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-5 / Eosinófilos / Subunidade alfa de Receptor de Interleucina-5 / Anticorpos Monoclonais Humanizados / Doenças do Sistema Imunitário Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Allergol Int Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel